The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DLL3-targeted therapy with tarlatamab in small cell lung cancer across lines of therapy: A systematic review of prospective and randomized clinical trials.
 
Hira Cheema
No Relationships to Disclose
 
Konstantinos Arnaoutakis
Stock and Other Ownership Interests - Athos Therapeutics
Honoraria - Academy for Continued Healthcare Learning; OncLive/MJH Life Sciences
Consulting or Advisory Role - Gilead Sciences